Dividends & Buybacks ·
VYNE Therapeutics Inc. declared a special cash dividend of approximately $0.38 per share, totaling an estimated $16.5…
VYNEYarrow Bioscience, Inc.
VYNE Therapeutics Inc. declared a special cash dividend of approximately $0.38 per share, totaling an estimated $16.5 million, in connection with its proposed merger with Yarrow Bioscience, Inc. The dividend is payable to stockholders and warrant holders of record as of July 22, 2062, and is expected to be paid on July 23, 2026. VYNE Therapeutics Inc. is a biotechnology company focused on developing therapeutic solutions.